Chembio Diagnostics, Inc

(NASDAQ:CEMI)

Latest On Chembio Diagnostics, Inc (CEMI):

Date/Time Type Description Signal Details
2023-04-13 18:37 ESTNewsBiosynex again extends tender offer for Chembio acquisitionN/A
2023-03-29 10:24 ESTNewsBiosynex extends tender offer period for Chembio acquisitionN/A
2023-02-01 02:30 ESTNewsChembio Diagnostics jumps ~26% postmarket after Biosynex to buy co in $17.2M dealN/A
2022-11-07 00:28 ESTNewsChembio Diagnostics, Inc. (CEMI) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 00:38 ESTNewsChembio Diagnostics GAAP EPS of -$0.21, revenue of $11.2MN/A
2022-09-06 23:37 ESTNewsChembio gets $3.2M contract from CDC to develop rapid test for syphilisN/A
2022-08-16 22:43 ESTNewsChembio stock rises 13% amid plans to develop rapid test for monkeypoxN/A
2022-08-07 21:20 ESTNewsChembio Diagnostics, Inc.'s (CEMI) CEO Rick Eberly on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 00:37 ESTNewsChembio Diagnostics GAAP EPS of -$0.23, revenue of $9.2MN/A
2022-06-15 23:42 ESTNewsChembio to self-distribute COVID test in US; offer HIV test via online platform in UK, BrazilN/A
2022-05-18 04:27 ESTNewsChembio's inks contract for HIV test to be made by Reszon Diagnostics at Malaysia facilityN/A
2022-05-08 12:36 ESTNewsChembio Diagnostics, Inc. (CEMI) CEO Rick Eberly on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-06 00:17 ESTNewsChembio Diagnostics GAAP EPS of -$0.29 misses by $0.08, revenue of $18.82M beats by $7.02MN/A
2022-05-05 01:00 ESTNewsChembio Diagnostics Q1 2022 Earnings PreviewN/A
2022-03-04 02:39 ESTNewsChembio Diagnostics GAAP EPS of $0.47 beats by $0.67, revenue of $20.6M beats by $7.05MN/A
2022-03-04 02:39 ESTNewsChembio Diagnostics, Inc. (CEMI) CEO Richard Eberly on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-03 09:09 ESTNewsChembio Diagnostics Q4 2021 Earnings PreviewN/A
2022-01-05 18:41 ESTNewsChembio Diagnostics appoints CFON/A
2021-12-29 17:04 ESTNewsChembio Diagnostics drops 20% after FDA declined to review EUA application for COVID/Flu testN/A
2021-12-06 12:52 ESTNewsChembio submits De Novo request SARS-CoV-2 Antigen test systemN/A
2021-12-06 12:52 ESTNewsChembio submits De Novo request SARS-CoV-2 Antigen test system (duplicate)N/A
2021-11-30 01:37 ESTNewsChembio Diagnostics jumps 10% after securing SAHPRA approval for DPP COVID-19 antigen testN/A
2021-11-16 17:42 ESTNewsChembio Diagnostics rises 8% after-hours after submitting EUA for COVID testN/A
2021-11-05 02:52 ESTNewsChembio Diagnostics EPS misses by $0.04, beats on revenueN/A
2021-11-04 05:42 ESTNewsChembio Diagnostics Q3 2021 Earnings PreviewN/A
2021-10-12 22:11 ESTNewsWarning: CEMI is at high risk of performing badlyN/A
2021-10-07 06:56 ESTNewsCEMI is at high risk of performing badlyN/A
2021-09-27 14:42 ESTNewsWarning: CEMI has been downgraded to Very BearishN/A
2021-09-22 23:32 ESTNewsWarning: CEMI has been downgraded to Very Bearish.N/A
2021-09-22 23:25 ESTNewsChembio submits EUA application for DPP respiratory antigen panelN/A
2021-08-28 01:39 ESTNewsChembio shares surge 18% after launch of third-party COVID-19 antigen assayN/A
2021-08-17 10:34 ESTNewsChembio Diagnostics, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-08 09:44 ESTNewsChembio Diagnostics, Inc. (CEMI) CEO Richard Eberly on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-05 23:49 ESTNewsChembio Diagnostics EPS beats by $0.06, misses on revenueN/A
2021-07-22 20:37 ESTNewsChembio diagnostics surges on purchase order for COVID-19 antigen test from BrazilN/A
2021-07-22 20:35 ESTNewsChembio Diagnostics downgraded at Colliers following 164% run-up todayN/A
2021-07-22 20:34 ESTNewsNeuroMetrix stock joins Reddit-driven rally with 60% rise in Q2 revenueN/A
2021-07-22 20:33 ESTNewsChembio Diagnostics gets $4M HIV test purchase orderN/A
2021-05-07 05:24 ESTNewsChembio Diagnostics EPS beats by $0.10, beats on revenueN/A
2021-04-06 00:27 ESTNewsChembio announces U.S. launch of point-of-care-test to differentiate COVID-19 and FluN/A
2021-03-16 20:26 ESTEarnings EstimateAn EPS average of -$0.94 is estimated for the 2022 year.Sell
2021-03-12 07:20 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 07:20 ESTEarnings EstimateAn EPS average of -$0.22 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-12 01:01 ESTNewsChembio Diagnostics EPS misses by $0.07, beats on revenueN/A
2021-03-12 01:01 ESTNewsChembio Diagnostics' (CEMI) CEO Rick Eberly on Q4 2020 Results - Earnings Call TranscriptN/A
2021-01-14 17:15 ESTNewsChembio stock gains after COVID-19 tests nab European Union nodN/A
2020-12-13 03:29 ESTFinancialsCompany financials have been released.Neutral
2020-12-05 00:36 ESTNewsFDA to delay Chembio's EUA application for rapid antibody test panelN/A
2020-12-05 00:36 ESTNewsChembio slumps 13% on delay of U.S. nod for coronavirus antibody testN/A
2020-12-04 03:22 ESTAnalyst RatingThe Analyst Target Price has increased from $6.25 to $9.Buy

About Chembio Diagnostics, Inc (CEMI):

Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, Hepatitis C, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, Rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.

CEMI Quotes by TradingView

See Advanced Chart

General

  • Name Chembio Diagnostics, Inc
  • Symbol CEMI
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Full Time Employees 355
  • Last Split Factor1:8
  • Last Split Date2012-05-30
  • Fiscal Year EndDecember
  • IPO Date2000-10-18
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Supplies
  • Web URLhttp://chembio.com
View More

Valuation

  • Forward PE 6.72
  • Price/Sales (Trailing 12 Mt.) 2.77
  • Price/Book (Most Recent Quarter) 3.21
  • Enterprise Value Revenue 3.01
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.15
  • Next Year EPS Estimate -$0.94
  • Next Quarter EPS Estimate -$0.24
  • Profit Margin -79%
  • Operating Margin -68%
  • Return on Assets -23%
  • Return on Equity -99%
  • Revenue 32.47 million
  • Earnings Per Share -$0.73
  • Revenue Per Share $1.7
  • Gross Profit -912784
  • Quarterly Earnings Growth 49.3%
View More

Highlights

  • Market Capitalization 84.97 million
  • EBITDA -10184776
  • PEG Ratio -0.48
  • Analyst Target Price $9
  • Book Value Per Share $1.38
View More

Share Statistics

  • Shares Outstanding 20.18 million
  • Shares Float 18.41 million
  • % Held by Insiders 1389%
  • % Held by Institutions 33.75%
  • Shares Short 2.19 million
  • Shares Short Prior Month 3.16 million
  • Short Ratio 2.38
  • Short % of Float 11%
  • Short % of Shares Outstanding 11%
View More

Technicals

  • Beta 1.96
  • 52 Week High $15.89
  • 52 Week Low $3.01
  • 50 Day Moving Average 5.99
  • 200 Day Moving Average 5.3
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Chembio Diagnostics, Inc (CEMI) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Chembio Diagnostics, Inc (CEMI) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-12$10.23 million-$0.35-$0.28-25%
2020-09-302020-11-05$10.27 million-$0.28-$0.26-7.69%
2020-06-302020-08-06$N/A-$0.42-$0.40-6.33%
2020-03-312020-05-04$N/A-$0.29-$0.23-27.47%
2019-12-312020-03-12$6.85 million-$0.23-$0.256.12%
2019-09-302019-11-07$9.72 million-$0.22-$0.17-29.41%
2019-06-302019-08-06$9.59 million-$0.19-$0.15-24.59%
2019-03-312019-05-01$8.3 million-$0.16-$0.15-6.67%
2018-12-312019-03-07$7.6 million-$0.21-$0.17-25.37%
2018-09-302018-11-08$9.38 million-$0.16-$0.12-33.33%
2018-06-302018-08-08$8.72 million-$0.12-$0.07-71.43%
2018-03-312018-05-09$7.72 million-$0.05-$0.1464.29%
2017-12-312018-03-08$5.99 million-$0.16-$0.11-49.95%
2017-09-302017-11-08$7.59 million-$0.05-$0.1154.55%
2017-06-302017-08-09$4.12 million-$0.18-$0.17-9.09%
2017-03-312017-05-09$6.33 million-$0.13-$0.2033.33%
2016-12-312017-03-07$4.26 million-$0.21-$0.17-25.97%
2016-09-302016-11-10$3.75 million-$0.19-$0.17-9.64%
2016-06-302016-08-11$3.27 million-$0.86-$0.17-405.88%
2016-03-312016-05-12$6.6 million-$0.03-$0.0966.67%
2015-12-312016-03-08$4.42 million-$0.07-$0.074.5%
2015-09-302015-11-12$6.89 million-$0.05-$0.0728.57%
2015-06-302015-08-06$6.72 million-$0.07
2015-03-312015-05-07$6.23 million-$0.07-$0.1136.36%
2014-12-312015-03-05$7.1 million-$0.05-$0.03-66.67%
2014-09-302014-11-06$7.31 million-$0.03-$0.02-50%
2014-06-302014-08-07$7.42 million-$0.02-$0.020%
2014-03-312014-05-08$5.81 million-$0.02-$0.01-100%
2013-12-312014-03-06$7.86 million-$0.03$0.04-175%
2013-09-302013-11-07$9.62 million$0.07$0.08-12.5%
2013-06-302013-08-08$5.39 million-$0.03-$0.0425%
2013-03-312013-05-09$6.68 million$0.04$0.02100%
2012-12-312013-03-07$7.87 million$0.06$0.0520%
2012-09-302012-11-13$5.01 million-$0.04$0.04-200%
2012-06-302012-08-09$6.08 million$0.04$0.0333.33%
2012-03-312012-05-08$6.65 million$0.08
2011-12-312012-03-08$6.22 million$0.66
2011-09-302011-11-03$5.92 million$0.06
2011-06-302011-08-04$3.61 billion$0.02
2011-03-312011-05-05$3.64 million-$0.02
2010-12-312011-03-03$5.67 million$0.24
2010-09-302010-11-04$4.51 million$0.02
2010-06-302010-07-29$3.75 million$0.08-$0.08200%
2010-03-312010-05-06$2.78 million-$0.02
2009-12-312010-03-05$3.55 million$0.03
2009-09-302009-11-05$4.36 million$0.03
2009-06-302009-08-07$3.37 million$0.01
2009-03-312009-05-08$2.55 million-$0.04
2008-09-302008-11-12$3.52 million-$0.03-$0.0861.75%
2008-06-302008-08-04$2.72 million-$0.08-$0.080%
2008-03-312008-05-12$2.37 million-$0.08-$0.1650%
2007-12-312008-03-12$2.38 million-$2.56-$0.80-220%
2007-09-302007-11-01$2.31 million-$0.56-$0.9641.67%
2007-06-302007-08-09$2.5 million-$0.65
2007-03-312007-05-11$2.04 million-$0.72-$1.0430.77%
2006-12-312007-03-29$2.61 million-$1.84-$0.96-91.67%
2006-09-302006-11-14$1.02 million-$1.70
2006-06-302006-08-14$1.64 million-$1.07
2006-03-312006-05-15$1.24 million-$1.72
2005-09-302005-11-14$944000-$1.02
2005-06-302005-08-14$906000-$1.17
2005-03-312005-05-15$732000-$4.03
2004-12-312005-03-23$1.16 million-$3.52
2004-09-302004-11-15$566000-$1.43
2004-06-302004-08-17$996000-$1.05
2004-03-312004-05-13$585000-$0.72
2003-09-302003-11-15$N/A$0.01
2003-06-302003-08-17$N/A-$0.01
2003-03-312003-03-31$N/A$0.05
2002-12-312002-12-31$N/A-$0.04
2001-06-302001-06-30$8000$0.12

Chembio Diagnostics, Inc (CEMI) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Chembio Diagnostics, Inc (CEMI) Chart:

Chembio Diagnostics, Inc (CEMI) News:

Below you will find a list of latest news for Chembio Diagnostics, Inc (CEMI) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Chembio Diagnostics, Inc (CEMI) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest CEMI Trades:

Date Shares Price
Jun 13, 2022 7:23 PM EST100$0.6936
Jun 13, 2022 7:29 PM EST100$0.6757
Jun 13, 2022 7:42 PM EST100$0.6794

Chembio Diagnostics, Inc (CEMI) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120014016/0001140361-20-014016-index.htm
2018-09-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1092662/000000000018029960/0000000000-18-029960-index.htm
2020-06-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1092662/000000000020005032/0000000000-20-005032-index.htm
2020-06-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1092662/000000000020005428/0000000000-20-005428-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1092662/000084608719000015/0000846087-19-000015-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1092662/000084608719000037/0000846087-19-000037-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1092662/000090221919000221/0000902219-19-000221-index.htm
2020-01-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1092662/000090630420000009/0000906304-20-000009-index.htm
2018-03-0810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1092662/000109266218000013/0001092662-18-000013-index.htm
2018-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000109266218000020/0001092662-18-000020-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1092662/000110465920021214/0001104659-20-021214-index.htm
2020-03-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1092662/000110580620000018/0001105806-20-000018-index.htm
2018-04-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118019625/0001140361-18-019625-index.htm
2018-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118019921/0001140361-18-019921-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1092662/000114036118022479/0001140361-18-022479-index.htm
2018-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118022509/0001140361-18-022509-index.htm
2018-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118024198/0001140361-18-024198-index.htm
2018-05-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118024282/0001140361-18-024282-index.htm
2018-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118024591/0001140361-18-024591-index.htm
2018-05-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118025605/0001140361-18-025605-index.htm
2018-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118026248/0001140361-18-026248-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118028738/0001140361-18-028738-index.htm
2018-07-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118032931/0001140361-18-032931-index.htm
2018-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118034159/0001140361-18-034159-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118035966/0001140361-18-035966-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1092662/000114036118035995/0001140361-18-035995-index.htm
2018-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118036236/0001140361-18-036236-index.htm
2018-08-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118036265/0001140361-18-036265-index.htm
2018-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118038547/0001140361-18-038547-index.htm
2018-09-18S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1092662/000114036118038659/0001140361-18-038659-index.htm
2018-10-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1092662/000114036118039749/0001140361-18-039749-index.htm
2018-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118040400/0001140361-18-040400-index.htm
2018-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118040401/0001140361-18-040401-index.htm
2018-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118040402/0001140361-18-040402-index.htm
2018-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118040404/0001140361-18-040404-index.htm
2018-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118040406/0001140361-18-040406-index.htm
2018-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118040407/0001140361-18-040407-index.htm
2018-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118040408/0001140361-18-040408-index.htm
2018-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118040410/0001140361-18-040410-index.htm
2018-10-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118040793/0001140361-18-040793-index.htm
2018-10-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118040795/0001140361-18-040795-index.htm
2018-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118040798/0001140361-18-040798-index.htm
2018-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118040799/0001140361-18-040799-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118041036/0001140361-18-041036-index.htm
2018-10-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1092662/000114036118041038/0001140361-18-041038-index.htm
2018-10-31424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1092662/000114036118041895/0001140361-18-041895-index.htm
2018-11-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1092662/000114036118042121/0001140361-18-042121-index.htm
2018-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118042339/0001140361-18-042339-index.htm
2018-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118042452/0001140361-18-042452-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118042759/0001140361-18-042759-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1092662/000114036118042769/0001140361-18-042769-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118042903/0001140361-18-042903-index.htm
2018-11-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036118043277/0001140361-18-043277-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036118045466/0001140361-18-045466-index.htm
2019-01-238-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119001391/0001140361-19-001391-index.htm
2019-01-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119001543/0001140361-19-001543-index.htm
2019-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119002877/0001140361-19-002877-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119004442/0001140361-19-004442-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119004572/0001140361-19-004572-index.htm
2019-03-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1092662/000114036119005069/0001140361-19-005069-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119005493/0001140361-19-005493-index.htm
2019-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119006279/0001140361-19-006279-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1092662/000114036119008079/0001140361-19-008079-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119008168/0001140361-19-008168-index.htm
2019-05-01DEFR14ARevised definitive proxy soliciting materialshttps://www.sec.gov/Archives/edgar/data/1092662/000114036119008194/0001140361-19-008194-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1092662/000114036119008232/0001140361-19-008232-index.htm
2019-05-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1092662/000114036119008668/0001140361-19-008668-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036119008669/0001140361-19-008669-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036119009826/0001140361-19-009826-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119009935/0001140361-19-009935-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119011520/0001140361-19-011520-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036119011532/0001140361-19-011532-index.htm
2019-07-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1092662/000114036119013107/0001140361-19-013107-index.htm
2019-07-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119013144/0001140361-19-013144-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119014341/0001140361-19-014341-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1092662/000114036119014369/0001140361-19-014369-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119014408/0001140361-19-014408-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119016127/0001140361-19-016127-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119016316/0001140361-19-016316-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119020032/0001140361-19-020032-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1092662/000114036119020057/0001140361-19-020057-index.htm
2019-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036119020481/0001140361-19-020481-index.htm
2019-11-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036119021382/0001140361-19-021382-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120000583/0001140361-20-000583-index.htm
2020-01-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120001160/0001140361-20-001160-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036120001172/0001140361-20-001172-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120004604/0001140361-20-004604-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120005684/0001140361-20-005684-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1092662/000114036120005780/0001140361-20-005780-index.htm
2020-03-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036120006258/0001140361-20-006258-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036120006259/0001140361-20-006259-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036120006260/0001140361-20-006260-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036120006261/0001140361-20-006261-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036120006262/0001140361-20-006262-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036120006263/0001140361-20-006263-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036120006264/0001140361-20-006264-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036120006265/0001140361-20-006265-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1092662/000114036120006266/0001140361-20-006266-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120006397/0001140361-20-006397-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120007757/0001140361-20-007757-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120009307/0001140361-20-009307-index.htm
2020-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1092662/000114036120010179/0001140361-20-010179-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120010614/0001140361-20-010614-index.htm
2020-05-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1092662/000114036120010632/0001140361-20-010632-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120010633/0001140361-20-010633-index.htm
2020-05-0610-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1092662/000114036120010767/0001140361-20-010767-index.htm
2020-05-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1092662/000114036120010828/0001140361-20-010828-index.htm
2020-05-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1092662/000114036120011018/0001140361-20-011018-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120011298/0001140361-20-011298-index.htm
2020-05-118-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120011303/0001140361-20-011303-index.htm
2020-05-29PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1092662/000114036120012751/0001140361-20-012751-index.htm
2020-06-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1092662/000114036120013209/0001140361-20-013209-index.htm
2020-06-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1092662/000114036120013971/0001140361-20-013971-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120014016/0001140361-20-014016-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120015539/0001140361-20-015539-index.htm
2020-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120015570/0001140361-20-015570-index.htm
2020-07-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1092662/000114036120015571/0001140361-20-015571-index.htm
2020-07-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1092662/000114036120015575/0001140361-20-015575-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120017393/0001140361-20-017393-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120017671/0001140361-20-017671-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1092662/000114036120017756/0001140361-20-017756-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1092662/000114036120024677/0001140361-20-024677-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1092662/000114036120024702/0001140361-20-024702-index.htm
2018-03-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1092662/000114420418017263/0001144204-18-017263-index.htm
2018-12-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1092662/000132531218000013/0001325312-18-000013-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1092662/000132531219000002/0001325312-19-000002-index.htm
2018-12-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1092662/000149315218017281/0001493152-18-017281-index.htm
2018-10-03EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1092662/999999999518002536/9999999995-18-002536-index.htm

Chembio Diagnostics, Inc (CEMI) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Chembio Diagnostics, Inc (CEMI). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1389%
Institutional Ownership: 3375%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-24Javan EsfandiariOfficerSell9,744.006.9567,726.65108,773.00https://www.sec.gov/Archives/edgar/data/1092662/000114036119009826/0001140361-19-009826-index.htm
2018-06-13Javan EsfandiariChief Science/Tech OfficerBuy20,000.005.64112,800.00111,258.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118028738/0001140361-18-028738-index.htm
2019-05-06Katherine Lyon DavisDirectorBuy46,875.003.48163,125.00112,943.00https://www.sec.gov/Archives/edgar/data/1092662/000114036119008669/0001140361-19-008669-index.htm
2019-05-23Javan EsfandiariOfficerSell12,956.007.1592,582.28118,517.00https://www.sec.gov/Archives/edgar/data/1092662/000114036119009826/0001140361-19-009826-index.htm
2019-05-22Javan EsfandiariOfficerSell7,300.007.4154,125.12131,473.00https://www.sec.gov/Archives/edgar/data/1092662/000114036119009826/0001140361-19-009826-index.htm
2018-10-08Javan EsfandiariOfficerBuy38,860.00138,773.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118040407/0001140361-18-040407-index.htm
2018-11-05Robert PassasOfficerBuy15,000.006.75101,250.0015,000.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118042452/0001140361-18-042452-index.htm
2018-10-08David GyorkeOfficerBuy20,725.0020,725.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118040799/0001140361-18-040799-index.htm
2018-05-16Sharon W KlugewiczPresident, AmericasBuy5,000.004.5022,500.0021,448.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118024591/0001140361-18-024591-index.htm
2018-11-14John Gary PotthoffDirectorBuy5,000.005.8029,000.0027,772.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118043277/0001140361-18-043277-index.htm
2018-11-14John Gary PotthoffDirectorBuy15,000.005.8187,150.0027,772.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118043277/0001140361-18-043277-index.htm
2019-11-11John Gary PotthoffDirectorBuy10,000.004.4444,400.0037,772.00https://www.sec.gov/Archives/edgar/data/1092662/000114036119020481/0001140361-19-020481-index.htm
2020-01-17GAIL S PAGEOfficerBuy30,864.0038,636.00https://www.sec.gov/Archives/edgar/data/1092662/000114036120001172/0001140361-20-001172-index.htm
2018-10-08Sharon W KlugewiczOfficerBuy20,725.0039,436.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118040406/0001140361-18-040406-index.htm
2018-10-08Neil A GoldmanOfficerBuy31,088.0045,903.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118040400/0001140361-18-040400-index.htm
2019-06-18John J III SperzelOfficerBuy375,000.00473,446.00https://www.sec.gov/Archives/edgar/data/1092662/000114036119011532/0001140361-19-011532-index.htm
2018-10-08Katherine Lyon DavisDirectorBuy7,772.0066,068.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118040402/0001140361-18-040402-index.htm
2018-10-08GAIL S PAGEDirectorBuy7,772.007,772.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118040404/0001140361-18-040404-index.htm
2018-10-08John Gary PotthoffDirectorBuy7,772.007,772.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118040408/0001140361-18-040408-index.htm
2018-10-08MARY LAKE PH D POLANDirectorBuy7,772.007,772.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118040410/0001140361-18-040410-index.htm
2018-10-08John J III SperzelOfficerBuy98,446.0098,446.00https://www.sec.gov/Archives/edgar/data/1092662/000114036118040401/0001140361-18-040401-index.htm